Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Nasdaq100 ETF (QQQ) Price & Performance

CVS Health CorpTrade
Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Nasdaq100 ETF — how do they compare? CVS Health Corp trades at $104.32 (market cap $135.48B), while Nasdaq100 ETF trades at $721.98. The key difference: CVS Health Corp pays a 2.51% dividend while Nasdaq100 ETF pays none. Which is the better fit depends on your goals.

CVSQQQ
Market Cap
$135.48B
Sector
Health
52-Week High
$106.18$746.16
52-Week Low
$58.75$553.88
Enterprise Value
$202.02B
Dividend Yield
2.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

Nasdaq100 ETF

QQQ, tracking the Nasdaq-100, trades at $711.79, down 1.9% over 24 hours amid a bearish technical signal. The ETF faces mixed sentiment with a 50/50 split in analyst ratings and news highlighting SpaceX's inclusion and competitive pressures from new funds like BlackRock's IQQ. Support sits near $700, with resistance at $717, while oscillators like the RSI remain neutral, suggesting indecision in the short term.

Outlook is cautious due to technical weakness and divided analyst views, though long-term exposure to tech giants offers growth potential. Risks include index concentration, fee competition, and macroeconomic shifts affecting rate-sensitive holdings, requiring careful monitoring of earnings trends from underlying companies.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

Read more on QQQ